Relationship between long-acting reversible contraception and acne in a cohort of adolescents and young adults

被引:1
|
作者
Boos, Markus D. [1 ,2 ,8 ]
Ryan, Morgan E. [3 ]
Milliren, Carly [3 ]
Golub, Sarah [4 ]
Maslyanskaya, Sofya [5 ]
Escovedo, Michelle [6 ]
Divasta, Amy [7 ]
Pitts, Sarah [7 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Div Dermatol, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA
[4] Univ Washington, Seattle Childrens Hosp, Sch Med, Dept Pediat, Seattle, WA USA
[5] Childrens Hosp Montefiore, Div Adolescent Med, New York, NY USA
[6] Childrens Hosp Los Angeles, Div Adolescent Young Adult Med, Los Angeles, CA USA
[7] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA
[8] Seattle Childrens Hosp, Dept Surg, 4800 Sand Point Way NE,OC9 833, Seattle, WA 98105 USA
关键词
acne; adolescence; long-acting reversible contraception; progestin;
D O I
10.1111/pde.15578
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of progestin-only long-acting reversible contraception (LARC) may be a risk factor for acne. Few studies have focused primarily on the effects of hormonal LARC on the development or exacerbation of acne in adolescents and young adults. We sought to understand the incidence and management of acne following hormonal LARC insertion in this adolescent/young adult population.MethodsA secondary data analysis was conducted of prospectively collected quality improvement (QI) data from the Adolescent Medicine LARC Collaborative. Subjects were evaluated by clinicians in adolescent medicine clinics at participating study sites, and acne severity was documented using a standardized recording instrument and scale. Descriptive statistics were reported as frequencies and percentages for categorical variables or mean and standard deviation (SD) for continuous variables. We compared demographic and clinical characteristics by those who had worsening acne, accounting for site inter-correlation using Cochran-Mantel-Haenszel chi-square tests for categorical variables and linear generalized estimating equation (GEE) regression for continuous variables.ResultsOf 1319 subjects who completed LARC insertion, 28.5% (376/1319) experienced worsening acne following use of progestin-only LARC. Acne was a contributing factor to LARC removal in only 3% (40/1319), and the sole reason for removal in 0.4% (5/1319) of all subjects. As this was a secondary analysis of prospectively collected QI data, limitations of this study include incomplete or inaccurate documentation of acne severity. Moreover, LARC insertions without follow-up/removal visits or with only follow-up/removal within 8 weeks of insertion were excluded from our study, which may also bias results.ConclusionsAdolescents and young adults seeking progestin-only LARC should be counseled about the potential for developing acne or experiencing a worsening of existing acne during LARC use. However, acne was not a common reason for LARC discontinuation.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [31] Effectiveness of Long-Acting Reversible Contraception
    Winner, Brooke
    Peipert, Jeffrey F.
    Zhao, Qiuhong
    Buckel, Christina
    Madden, Tessa
    Allsworth, Jenifer E.
    Secura, Gina M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 1998 - 2007
  • [32] What Is Long-Acting Reversible Contraception? Long-acting reversible contraception (LARC) is long-lasting and easily reversible birth control
    Stark, Elisabeth L.
    Gariepy, Aileen M.
    Son, Moeun
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (13): : 1362 - 1362
  • [33] Internet-Based Information on Long-Acting Reversible Contraception for Adolescents
    Harris, Kari
    Byrd, Kelly
    Engel, Matt
    Weeks, Kerri
    Ahlers-Schmidt, Carolyn R.
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2016, 7 (02): : 76 - 80
  • [34] Pediatric Provider Education and Use of Long-Acting Reversible Contraception in Adolescents
    Smith, Anna Jo Bodurtha
    Hurwitz, Anita Gupta
    Singh, Tara
    Harney, Kathleen F.
    JOURNAL OF PEDIATRIC HEALTH CARE, 2019, 33 (02) : 146 - +
  • [35] Long-acting reversible contraception for adolescents and young adults - A cross-sectional study of women and general practitioners in Oslo, Norway
    Bratlie, Marte
    Aarvold, Trine
    Skarn, Elling Skeide
    Lundekvam, Jonas Andre
    Nesheim, Britt-Ingjerd
    Askevold, Erik Tandberg
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2014, 19 (03): : 194 - 202
  • [36] Outcomes of a two-visit protocol for long acting reversible contraception for adolescents and young adults
    Wilkinson, Tracey A.
    Edmonds, Brownsyne Tucker
    Cheng, Erika R.
    CONTRACEPTION, 2022, 105 : 33 - 36
  • [37] Outcomes of a Two-Visit Protocol for Long Acting Reversible Contraception for Adolescents and Young Adults
    Wilkinson, Tracey A.
    Edmonds, Brownsyne Tucker
    Cheng, Erika R.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (12) : 747 - 749
  • [38] Predictors of Discontinuation of Long-Acting Reversible Contraception Before 30 Months of Use by Adolescents and Young Women
    Cohen, Rebecca
    Sheeder, Jeanelle
    Teal, Stephanie B.
    JOURNAL OF ADOLESCENT HEALTH, 2019, 65 (02) : 295 - 302
  • [39] Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents
    Kortsmit, Katherine
    Williams, Letitia
    Pazol, Karen
    Smith, Ruben A.
    Whiteman, Maura
    Barfield, Wanda
    Koumans, Emilia
    Kourtis, Athena
    Harrison, Leslie
    Bauman, Brenda
    Warner, Lee
    JAMA PEDIATRICS, 2019, 173 (07) : 663 - 670
  • [40] EARLY DISCONTINUATION OF LONG-ACTING REVERSIBLE CONTRACEPTION
    Grunloh, D.
    Casner, T.
    Secura, G.
    Peipert, J.
    Madden, T.
    CONTRACEPTION, 2013, 88 (03) : 438 - 438